Dec'23 | |
---|---|
P/EBITDA LTM | 4.0x |
Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 71.2 0.0% | 152.3 113.7% | 326.2 114.2% | 517.7 58.7% |
Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.1 | 114.6 | 259.0 | 417.8 |
% margin | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 21.1 29.7% | 37.7 24.8% | 67.2 20.6% | 99.8 19.3% |
Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 4.7 | 2.7 | 27.8 |
Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative Expenses (SG&A) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.7 | 5.0 | 5.1 | 5.7 |
% margin | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 17.6 24.7% | 33.0 21.7% | 65.2 20.0% | 72.0 13.9% |
Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.8 | 0.2 | 3.0 |
Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 1.9 | 18.0 | 32.5 |
Pre-tax Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.2 | 32.6 | 45.1 | 21.8 |
% effective tax rate | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 3.3 20.2% | 7.0 21.5% | 8.7 19.3% | 18.4 84.2% |
% margin | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | (1.7) (2.4%) | 1.7 1.1% | 31.3 9.6% | (12.5) (2.4%) |
EPS | N/A | N/A | N/A | N/A | N/A | N/A | (0.05) | 0.06 | 0.56 | (0.23) |
Diluted EPS | N/A | N/A | N/A | N/A | N/A | N/A | (0.05) | 0.06 | 0.56 | (0.23) |
% margin | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 21.7 30.5% | 44.1 29.0% | 86.2 26.4% | 95.0 18.3% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, Microsoft Corp's last 12-month P/EBITDA LTM is 3.5x, based on the financial report for Sep 27, 2024 (Q3’2024). The average annual P/EBITDA LTM for Ambipar Emergency Response have been 2.0x over the past three years, and 1.5x over the past five years.
As of today, Ambipar Emergency Response's P/EBITDA LTM is 3.5x, which is lower than industry median of 9.4x. It indicates that Ambipar Emergency Response's P/EBITDA LTM is Good.